Effects of Sodium-glucose cotransporters 2 (SGLT2) inhibitors on urinary albumin creatinine ratio (UACR) in randomized controlled trials (RCTs) in patients with type 2 diabetes and chronic kidney disease (CKD) of different levels. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.